Menu

ARIXTRA 5 mg, 7,5 mg et 10 mg (fondaparinux), anticoagulant

Active substance (DCI)

fondaparinux sodium

Cardiologie - Mise au point

Reason for request
Re-assessment of the Actual Benefit at the request of the Committee (pursuant to Article R 163-21 of the French Social Security Code) following questions raised by the Afssaps (French Health Products Safety Agency) on 28 December 2011